Acumen LLC

Acumen LLC, doing business as Medric, provides healthcare data analytics, research support, and technical assistance to federal health agencies as a prime contractor (98% of awards) across CMS, FDA, NIH, CDC, and HRSA, with work performed principally from Hillsborough and Burlingame, California. The company is a for-profit limited liability partnership operating in full-and-open competition — no set-asides recur across its prime footprint — with a $18.15 billion combined potential value across 217 federal awards and $1.17 billion obligated to date.

Customer concentration is extreme. The Centers for Medicare and Medicaid Services dominates with 133 awards and $15.28 billion in combined potential value, representing 84% of all prime awards and 84% of total potential value. The top five customer agencies account for 79% of award count and 99% of potential value. Within CMS, Acumen anchors work on indefinite-delivery vehicles supporting payment system analytics, measure development, research initiatives, and data-linking services for Medicare and Medicaid programs. Recent prime work includes a $77.3 million delivery order (September 30, 2026, through June 29, 2031) under the GSA Multiple Award Schedule for data analytics and technical assistance across CMS payment systems, providers, and beneficiaries; a $40.8 million FDA definitive contract (September 30, 2026, through September 29, 2029) for the Biologics Effectiveness and Safety (BEST) Initiative post-market surveillance of biologic products; and a $57.4 million CMS delivery order (January 3, 2025, through January 2, 2033) under the Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2) IDIQ to implement and monitor the Transforming Episode Accountability Model (TEAM).

Acumen holds positions on multiple government-wide and agency-specific vehicles. On the GSA Multiple Award Schedule (MAS), 68 task orders carry $693.6 million in combined potential value. The RMADA vehicle family across CMS carries 11 task orders worth $242.7 million, supporting research, measurement, and analytic services for healthcare policy and program evaluation. The Measure and Instrument Development and Support (MIDS 2) IDIQ under CMS carries 10 task orders worth $169.3 million for healthcare quality measurement and policy support. Acumen also holds a $3.5 billion RMADA 3 IDIQ awarded July 9, 2026, a $75 million FDA BEST #3 IDIQ awarded September 27, 2024, for healthcare data sources for surveillance of biologics, a $344.7 million single-award HRSA Evaluations and Evidence Building IDIQ awarded September 26, 2024, and a $149 million CDC Vaccine Safety Datalink IDIQ awarded September 20, 2022. Acumen was also awarded a seat on the OASIS+ Unrestricted government-wide acquisition contract in December 2024 (ceiling not specified), covering management consulting and IT professional services.

SCI-reported invoicing shows stable federal services delivery: $101.9 million in FY2022, $110.9 million in FY2023, $109.5 million in FY2024, and $99.8 million in FY2025. Government-paid hourly rates on federal service contracts range from $115.79/hr at the 10th percentile to $194.94/hr at the 90th percentile, reflecting a labor portfolio centered on research analysts, data scientists, and technical management roles. The SCI dataset shows 131 to 169 FTEs per fiscal year performing on prime contracts, though this is a subset of the vendor's total federal workforce. Across SCI-reportable prime contracts, subcontractors performed approximately 46 percent of contractor hours, with 235 named subcontractors reported cumulatively. On the GSA MAS, Acumen's active labor portfolio spans 35 categories, from Research Analyst ($92.23/hr) through Senior Research Partner ($469.06/hr, PhD, 20 years experience), with no security-cleared positions offered.

Activity has grown modestly in recent years — 8 awards in 2022, 3 in 2023, 8 in 2024, 4 in 2025, and 12 in 2026 (as of September 30, 2026) — indicating recent acceleration. Thirteen awards with ultimate completion dates in the next twenty-four months carry combined potential value of $291.9 million, representing material recompete exposure. Acumen operates as a sub-contractor in only 5 of 217 awards (2%), including a sub-award to Leidos under an ITSSC task order and multiple sub-awards as a data-management and analysis partner to Brown University under NIH grants covering Medicare claims linkage, nursing home data integration, and vaccine monitoring initiatives. The vendor's subcontractor role positions it as a specialized data management and claims-linkage service provider to academic and prime-contractor beneficiaries of healthcare research.